REPL

Replimune Group, Inc.

Biological Products, (No Diagnostic Substances)NasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

46

Buys

0

Sells

39

Largest Trade

$1M+

Insiders

13

Institutional Funds

120

Inst. Value

$1M+

Activist Filings

37

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Dhingra KapilDirectorSELL$15K–$50K3K$10.40Dec 11, 2025
Dhingra KapilDirectorEXERCISE$1K–$15K3K$1.75Dec 11, 2025
Patel SushilCEOSELL$100K–$500K10K$11.13Dec 4, 2025
Sarchi ChristopherChief Commercial O…SELL$15K–$50K5K$9.10Nov 19, 2025
Xynos KonstantinosChief Medical Offi…SELL$50K–$100K7K$9.10Nov 19, 2025
Astley-Sparke PhilipDirectorSELL$100K–$500K32K$8.06May 23, 2025
Xynos KonstantinosChief Medical Offi…SELL$50K–$100K8K$8.06May 23, 2025
Schwendenman AndrewChief Accounting O…SELL$15K–$50K3K$8.05May 23, 2025
Patel SushilCEOSELL$100K–$500K25K$8.06May 23, 2025
Hill Emily LuisaCFOSELL$15K–$50K3K$8.05May 23, 2025
Sarchi ChristopherChief Commercial O…SELL$15K–$50K4K$8.05May 23, 2025
Xynos KonstantinosChief Medical Offi…SELL$50K–$100K7K$10.78Nov 21, 2024
Sarchi ChristopherChief Commercial O…SELL$50K–$100K5K$10.78Nov 21, 2024
Hill Emily LuisaCFOSELL$50K–$100K9K$10.18Aug 20, 2024
Xynos KonstantinosChief Medical Offi…SELL$100K–$500K16K$7.50Jun 11, 2024
Xynos KonstantinosChief Medical Offi…SELL$50K–$100K7K$10.92Nov 18, 2023
Sarchi ChristopherChief Commercial O…SELL$50K–$100K5K$10.92Nov 18, 2023
Esposito PamelaChief Business Off…SELL$100K–$500K6K$20.01Sep 14, 2023
Esposito PamelaChief Business Off…EXERCISE$15K–$50K6K$3.30Sep 14, 2023
Esposito PamelaChief Business Off…EXERCISE$100K–$500K19K$6.58Aug 25, 2023
Esposito PamelaChief Business Off…SELL$100K–$500K19K$20.01Aug 25, 2023
Esposito PamelaChief Business Off…SELL$15K–$50K1K$20.00Aug 16, 2023
Esposito PamelaChief Business Off…EXERCISE$1K–$15K1K$3.30Aug 16, 2023
Esposito PamelaChief Business Off…SELL$100K–$500K20K$21.58Jul 12, 2023
Esposito PamelaChief Business Off…EXERCISE$100K–$500K20K$6.35Jul 12, 2023
Lewis TanyaChief Dev. Op. Off…SELL$100K–$500K13K$24.06Jun 16, 2023
Patel SushilChief Strategy Off…SELL$100K–$500K6K$24.05Jun 16, 2023
Patel SushilChief Strategy Off…SELL$100K–$500K16K$18.05May 19, 2023
Coffin RobertPresident & Chief …SELL$100K–$500K8K$18.05May 19, 2023
Lewis TanyaChief Dev. Op. Off…SELL$100K–$500K12K$18.05May 19, 2023
Love ColinCOOSELL$100K–$500K11K$18.05May 19, 2023
Franchi Jean M.CFOSELL$100K–$500K11K$18.05May 19, 2023
Xynos KonstantinosChief Medical Offi…SELL$1K–$15K771$18.05May 19, 2023
Esposito PamelaChief Business Off…SELL$100K–$500K6K$18.05May 19, 2023
Astley-Sparke PhilipCEOSELL$100K–$500K18K$18.05May 19, 2023
Esposito PamelaChief Business Off…SELL$100K–$500K15K$25.03Dec 14, 2022
Esposito PamelaChief Business Off…EXERCISE$15K–$50K15K$1.01Dec 14, 2022
Love ColinCOOSELL$50K–$100K6K$14.59May 18, 2022
Esposito PamelaChief Business Off…SELL$50K–$100K4K$14.59May 18, 2022
Franchi Jean M.CFOSELL$50K–$100K3K$14.59May 18, 2022
Lewis TanyaChief Dev. Op Offi…SELL$50K–$100K5K$14.59May 18, 2022
Patel SushilChief Commercial O…SELL$100K–$500K11K$14.59May 18, 2022
Coffin RobertPresident & Chief …SELL$50K–$100K6K$14.59May 18, 2022
Astley-Sparke PhilipCEOSELL$100K–$500K10K$14.59May 18, 2022
Omega Fund IV, L.P.10% OwnerEXERCISE$100K–$500K17K$9.78Mar 17, 2022
Omega Fund IV, L.P.10% OwnerSELL$1M+107K$15.55Mar 17, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Redmile Group, LLC

SC 13G/A · Nov 14, 2025

0.7%

536K shares

Point72 Asset Management, L.P.

SC 13G/A · Nov 14, 2025

4.7%

3.6M shares

T. Rowe Price Associates, Inc.

SC 13G/A · Nov 14, 2025

10.6%

8.3M shares

RTW Investments, LP

SC 13G · Nov 14, 2025

8.2%

6.4M shares

Point72 Asset Management, L.P.

SC 13G · Jul 31, 2025

5.7%

4.5M shares

Redmile Group, LLC

SC 13G/A · May 16, 2025

6.4%

4.9M shares

Baker Bros. Advisors LP

SC 13D · Mar 7, 2025

14.3%

11.0M shares

6.1%

4.2M shares

The Vanguard Group

SC 13G/A · Jan 31, 2025

4.8%

3.6M shares

Baker Bros. Advisors LP

SC 13G/A · Nov 14, 2024

16.2%

11.0M shares

14.5%

9.9M shares

Omega Fund IV, L.P.

SC 13G/A · Nov 14, 2024

4.0%

2.7M shares

7.5%

5.1M shares

The Vanguard Group

SC 13G/A · Nov 12, 2024

5.1%

3.5M shares

The Vanguard Group

SC 13G/A · Nov 4, 2024

5.1%

3.5M shares

Morgan Stanley I.R.S. # 36-3145972

SC 13G/A · Oct 7, 2024

2.3%

1.5M shares

10.7%

6.5M shares

Omega Fund IV, L.P.

SC 13G/A · Feb 14, 2024

5.5%

3.2M shares

Redmile Group, LLC

SC 13G/A · Feb 14, 2024

7.4%

4.6M shares

9.9%

5.9M shares

8.7%

5.2M shares

BlackRock, Inc.

SC 13G/A · Jan 26, 2024

7.7%

4.5M shares

Baker Bros. Advisors LP

SC 13G/A · Jan 10, 2024

16.2%

9.5M shares

Redmile Group, LLC

SC 13G/A · Feb 14, 2023

9.9%

5.7M shares

Baker Bros. Advisors LP

SC 13G · Feb 14, 2023

10.0%

5.8M shares

9.2%

5.1M shares

Omega Fund IV, L.P.

SC 13G/A · Feb 13, 2023

7.2%

3.6M shares

BlackRock, Inc.

SC 13G · Feb 3, 2023

5.5%

3.0M shares

ATLAS VENTURE FUND X, L.P.

SC 13D/A · Dec 6, 2022

3.0%

1.5M shares

Redmile Group, LLC

SC 13G/A · Nov 18, 2022

9.9%

5.2M shares

ATLAS VENTURE FUND X, L.P.

SC 13D/A · Sep 14, 2022

4.4%

2.2M shares

Redmile Group, LLC

SC 13G/A · Feb 14, 2022

9.9%

4.8M shares

Omega Fund IV, L.P.

SC 13G/A · Feb 14, 2022

10.6%

5.0M shares

12.5%

5.9M shares

View on Google Finance →